Cleveland, Targeting lactate metabolism for cancer therapeutics
Error bars show the standard deviation of the three replicate experiments
Cagrilintide is a long-acting acylated analogue of human amylin (islet amyloid polypeptide), molecular formula CHNOS, molecular weight 4409.0 g/mol, CAS 1415456-99-3, developed by Novo Nordisk under the codes AM833 and NNC0174-0833
The same study found that for non-alcoholic cirrhosis, 4 or more cups per day conferred a 30% reduced risk of cirrhosis (Klatsky 2006)
It inhibits inflammation, regulates the production and balance of skin sebum
The medications are also being studied in late stages of clinical development for chronic kidney disease and non-alcoholic fatty liver disease, where theyve shown promise